ERBB3, erb-b2 receptor tyrosine kinase 3, 2065

N. diseases: 318; N. variants: 16
Disease: Prostatic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. 18852121 2008
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 AlteredExpression group LHGDN Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. 18559590 2008
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. 17634423 2007
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group CTD_human Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. 17634423 2007
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. 17638862 2007
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN Expression and nuclear localization of ErbB3 in prostate cancer. 16675564 2006